6:09 PM
 | 
Feb 06, 2013
 |  BC Extra  |  Politics & Policy

FDA: pre-IND meeting cuts development time

For all new drugs approved during 2010-12, the average clinical development time was more than three years faster when a pre-IND meeting was held with FDA than for approved drugs that...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >